Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 16.46.
Forward PE Ratio (16.46) = Close Price ($76.22) / Consensus Forward EPS ($4.63)
FORWARD PE RATIO
16.46
SECTOR MEDIAN · HEALTHCARE
19.91
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-17.35%
vs the sector median at left
The Cooper Companies, Inc.
Market Cap
$14.87B
Forward PE Ratio
16.46
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| The Cooper Companies, Inc. (COO) | $14.87B | 16.46 |
| Solventum Corporation (SOLV)vs › | $15.51B | 12.51 |
| Charles River Laboratories International, Inc. (CRL)vs › | $14.22B | 26.08 |
| Revvity, Inc. (RVTY)vs › | $13.92B | 23.29 |
| Baxter International Inc. (BAX)vs › | $13.62B | 12.83 |
| Exelixis, Inc. (EXEL)vs › | $13.59B | 18.14 |
| Tempus AI, Inc. (TEM)vs › | $12.74B | N/A |
| Medpace Holdings, Inc. (MEDP)vs › | $17.33B | 35.27 |
| Align Technology, Inc. (ALGN)vs › | $11.64B | 14.40 |
| Bio-Techne Corporation (TECH)vs › | $11.32B | 37.61 |
Trailing P/E
64.6
reported TTM EPS
Forward P/E
16.5
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $4.63 implies +292.4% EPS growth vs the reported trailing $1.18.
At today's $76.22 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-10-31 | $4.63 | $4.61 – $4.67 | 11 | 16.5x |
| 2027-10-31 | $5.01 | $4.93 – $5.08 | 11 | 15.2x |
| 2028-10-31 | $5.43 | $4.53 – $6.17 | 8 | 14.0x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
